Vanguard Global Advisers’s Amicus Therapeutics FOLD Stock Holding History

Vanguard Global Advisers’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-123,373	Closed	-$1.78M	–	3679
2026 Q1	$1.78M	Buy	+123,373	New	+$1.77M	﹤0.01%	1265

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Vanguard Global Advisers's FOLD Position: Q2 2026 in Review

Vanguard Global Advisers sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 123,373 shares — an estimated $1.78M sold.

Vanguard Global Advisers first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $1.78M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Vanguard Global Advisers reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Vanguard Global Advisers sold 123,373 Amicus Therapeutics shares in Q2 2026, an estimated $1.78M.
Vanguard Global Advisers first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
Vanguard Global Advisers's Amicus Therapeutics position peaked at $1.78M in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.